5442932026-04-012026-06-305442932026-04-012026-06-30in-capmkt:OtherExpenses1Member5442932026-04-012026-06-30in-capmkt:OtherExpenses2Member5442932026-04-012026-06-30in-capmkt:OtherExpenses3Member5442932026-04-012026-06-30in-capmkt:OtherExpenses4Member5442932026-04-012026-06-30in-capmkt:OtherExpenses5Member5442932026-04-012026-06-30in-capmkt:OtherExpenses6Member5442932026-04-012026-06-30in-capmkt:OtherExpenses7Member5442932026-04-012026-06-30in-capmkt:OtherExpenses8Member5442932026-04-012026-06-30in-capmkt:OtherExpenses9Member5442932026-04-012026-06-30in-capmkt:OtherExpenses10Member5442932026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15442932026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25442932026-04-012026-06-30AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares544293SURAKSHANOTLISTEDINE877V01027SURAKSHA DIAGNOSTIC LIMITEDMain BoardEquity2026-04-012027-03-312026-08-122026-08-04INRLakhsQuarterlyFirst quarterSingle segmentDIAGNOSTIC2026-08-1215:00:002026-08-1216:30:00Declaration of unmodified opinionfalsefalseNot Appliacble2026-04-012026-06-30UnauditedStandalone84086200015641000856503000971160000013852600036700000106009000316028000694379000162124000016212400041931000-56270003630400001258200000000125820000142400012724400010416200022.422.42002.422.420001. The unaudited standalone financial results for the quarter ended 30 June 2026 (“the financial results”) of Suraksha Diagnostic Limited (“the Company”) have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard (Ind AS) notified under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder and other accounting principles generally accepted in India and in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“the Regulations”). <br /> These unaudited standalone financial results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors in their respective meeting held on 12 August 2026. The statutory auditor have carried out limited review on these financial results and have issued an unmodified conclusion. <br /> 2. The figures of the quarters ended 31 March 2026 is balancing figures between the audited figures in respect of the full financial year and the published figures of nine months ended 31 December 2025, which were subjected to limited review by the statutory auditors. <br /> 3. The Company is primarily engaged in the business of diagnostic centres for carrying out various pathology and radiology services and as such there are no separate reportable segments as per Ind AS 108 – ‘Operating Segments’. <br /> 4. In a step-down subsidiary of the Company, a dispute with the Government of Meghalaya (the public partner) has resulted in operational losses. As a result, the recoverability of the Company’s investments, loans advanced to subsidiary and trade receivables from step-down subsidiary aggregating to Rs. 393.67 lakhs as at 30 June 2026 is under assessment. <br /> The Management has initiated arbitration proceedings through its subsidiary and the next hearing is scheduled on 21 August 2026 at the Hon'ble High Court of Meghalaya. The Company's management believes that the outcome of the arbitration will be in their favour. However, considering the dispute is subjudice, the management on prudent basis has provided Rs. 81.16 lakhs towards provisions on the said balances in the financial results. <br /> 5. These unaudited standalone financial results are also available on the Company's website (www.surakshanet.com) and on the stock exchange websites (www.bseindia.com and www.nseinda.com). <br /> 6. Previous period's/year's figures have been regrouped/reclassified wherever necessary to conform to current period’s/ year's classification. <br /> <br /> Impairment Loss7596000Advertisement5852000Rent Expenses13518000Power and fuel25095000Professional fees paid138668000Repairs and maintenance17513000Information technology expenses14858000Security and housekeeping charges23214000Commission to collection centre17946000Other Expenses51768000Remeasurement gain/(loss) of net defined benefit plan1902000Income tax effect on above-4780001424000001424000UnauditedfalseMSKA & Associatestrue2027-07-31